Medroxyprogesterone

Medroxyprogesterone is a type of hormone medicine. It's often used to help control periods, prevent pregnancy, or treat certain types of cancer. It's sometimes used in animals too, but the main use is in people.

Medication

What people taking Medroxyprogesterone report

Every report comes from a Lived member, sent anonymously.

Have you tried Medroxyprogesterone for Menopause?

NameHow it went

About Medroxyprogesterone

What It's For

Medroxyprogesterone acetate is a man-made version of progesterone, the hormone that prepares the uterus each month and helps regulate the menstrual cycle. It comes in two very different forms that are used for different reasons. As an injection, it is best known as Depo-Provera, often called "the shot," a birth control method given every three months. Depo-Provera CI is injected into a muscle. A lower-dose version, depo-subQ provera 104, is injected just under the skin and is approved both for preventing pregnancy and for managing pain from endometriosis, a condition in which tissue similar to the uterine lining grows outside the uterus. As a tablet, sold as Provera and as generics, it is not used for birth control. Short courses can bring on a period in someone whose periods have stopped for reasons other than pregnancy or menopause, or treat abnormal bleeding caused by hormone imbalance once problems such as fibroids or cancer have been ruled out. After menopause, it is also taken alongside estrogen by people who still have a uterus, to protect the uterine lining.

How It Works

The injection contains enough medroxyprogesterone to suppress signals from the brain that normally ripen and release an egg each month. Without ovulation there is no egg to fertilize. It also thickens the mucus at the cervix, making it harder for sperm to get through, and thins the lining of the uterus. Lower estrogen levels and a thinner lining explain several of the shot's typical effects, including lighter or absent periods and its effect on bone. The tablets work differently. At usual doses they do not reliably stop ovulation, which is why they are not birth control. Instead, they change the uterine lining from its growing phase into the phase that normally follows ovulation. When the tablets are stopped, hormone levels fall and the lining sheds as a period, usually within three to seven days. When estrogen is taken after menopause, it makes the lining grow; adding medroxyprogesterone counters that growth and lowers the chance of overgrowth (endometrial hyperplasia), which can lead to uterine cancer.

Dosage & Administration

The muscle injection is given every 3 months (13 weeks), usually in the buttock or upper arm. The under-the-skin version is given every 12 to 14 weeks into the thigh or abdomen. Its label calls for a clinician to give it, but contraception guidance from the Centers for Disease Control and Prevention (CDC) recommends that self-injection at home be made available, and some clinics teach people to do it themselves. The first shot is timed or checked to make sure the person is not already pregnant; if it is not given early in a period, a backup method such as condoms is needed for the first 7 days. Protection depends on staying on schedule. A repeat injection can be up to 2 weeks late (15 weeks after the last shot) without losing protection. Beyond that, a clinician will want to rule out pregnancy, and backup contraception is needed for 7 days after the late shot. Setting a reminder for the next appointment is one of the most useful things a user can do. Tablets are taken by mouth for a set number of days, commonly 5 to 10 days for missed or irregular periods, or 12 to 14 days each month alongside estrogen after menopause. The exact plan depends on the reason it is prescribed.

Side Effects

Changes in bleeding are the most common effect of the shot. In the first months many people have irregular, unpredictable bleeding or spotting, which can be frustrating and is the main reason people stop. Over time bleeding usually decreases, and about half of users have no periods at all after a year. This is expected and not harmful. Weight gain is also common: in studies, users gained an average of about 5 pounds in the first year and about 8 pounds over two years, though individual changes vary widely. Headaches, nervousness, abdominal discomfort, lower sex drive and dizziness are other reported effects. Some people notice mood changes, and anyone with a history of depression should report a return of symptoms. Tablets can cause spotting or changes in bleeding, breast tenderness, headache, nausea, and bloating or fluid retention. Serious problems are uncommon but important to recognize. Call the care team right away for unusually heavy vaginal bleeding, severe pain or tenderness in the lower abdomen (which can signal a pregnancy outside the uterus), severe pain or swelling in one calf, or persistent pain, pus or bleeding at the injection site. Call 911 for sharp chest pain, coughing up blood or sudden shortness of breath, or for a sudden severe headache, trouble speaking or seeing, or weakness or numbness in an arm or leg, since these can signal a blood clot in the lung or a stroke.

Interactions & Warnings

The shot carries an FDA boxed warning about bone loss. Because it lowers estrogen, users lose bone mineral density, the measure of how dense and strong bones are, and the loss grows the longer the shot is used. It may not fully recover, which matters most for teenagers and young adults who are still building bone. For this reason the label advises against using it for more than 2 years unless other methods are not suitable. The American College of Obstetricians and Gynecologists (ACOG) takes a less restrictive view: bone density largely recovers after stopping, the effect on later fracture risk is unproven, and these concerns alone should not prevent use beyond 2 years. People with other risks for weak bones, such as an eating disorder, heavy alcohol or tobacco use, or long-term steroid or seizure medicines, should weigh this more carefully with their clinician. When the tablets are taken with estrogen after menopause, the combination carries a different boxed warning. In the Women's Health Initiative, a large trial of estrogen plus medroxyprogesterone in women aged 50 to 79, the combination increased the risk of blood clots, stroke, heart attack and invasive breast cancer, and in women 65 and older, probable dementia. Hormone therapy is therefore used at the lowest effective dose for the shortest time that meets the person's goals, and never to prevent heart disease or dementia. Medroxyprogesterone is generally not used by people who have or have had blood clots or a stroke, who have or may have breast cancer, who have significant liver disease, or who have vaginal bleeding that has not been explained. The tablets are not taken during pregnancy. Cases of meningioma, a usually noncancerous brain tumor, have been reported mainly with long-term injection use, so anyone with a history of meningioma should raise it before starting. Some medicines speed up the breakdown of hormones and may make the shot less effective, including rifampin (an antibiotic for tuberculosis), several seizure medicines such as carbamazepine, phenytoin and topiramate, and the herbal supplement St. John's wort. A backup method or a different method may be advised while taking them. The shot does not protect against HIV or other sexually transmitted infections; condoms are needed for that.

What to Expect

The shot is one of the more effective forms of birth control as people actually use it: about 4 in 100 users become pregnant in the first year, mostly because an injection is late or missed. It requires no daily action, and many people value its privacy and the lighter periods that develop over time. The trade-off is the unpredictable bleeding of the early months and the fact that its effects cannot be stopped once a dose is given; they wear off over the following months. That slow wear-off also affects plans for pregnancy. Fertility returns later than with the pill or an intrauterine device (IUD). Among people who stopped to conceive, half of those who became pregnant did so within about 10 months of the last shot, and most within 18 months, regardless of how long they had used it. Someone who wants to become pregnant within the next year or so may prefer a method with a quicker return. Short courses of tablets usually bring on a withdrawal period within a week of the last dose. If bleeding problems continue or return, a clinician will look for other causes rather than simply repeating treatment. People taking tablets with estrogen after menopause typically review every few months whether hormone therapy is still needed, and any unexpected bleeding should be checked. Everyone using a hormonal method is advised to have a yearly visit that includes a blood pressure check.

Questions to Ask Your Doctor

  1. 1.Given my age, bone health and future pregnancy plans, is the shot a good fit for me compared with an implant, IUD or pill?
  2. 2.How long do you expect me to stay on it, and how will we think about bone health if I use it for more than two years?
  3. 3.What should I do if I cannot get my next injection on time, and could I learn to give the under-the-skin version myself?
  4. 4.How long will the irregular bleeding likely last, and what can we do if it does not settle?
  5. 5.If I am taking the tablets with estrogen, how long should I continue, and how will we review the risks over time?

Last reviewed • Oct 2026

Educational content, not medical advice.